Evidence map›Paper›PMID 31367849›Full record

ReviewCurrent cardiology reports2019

The Assessment of Cardiac Masses by Cardiac CT and CMR Including Pre-op 3D Reconstruction and Planning.

Stephen Liddy, Colin McQuade, Kevin P Walsh, Bryan Loo, Orla Buckley

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Advancing cardiac tumor diagnosis: evaluatingAmerican journal of cardiovascular disease · 2026
    Review
  5. Article
  6. Cardiac computed tomography for cardiac masses: a necessity or a luxury?The Journal of international medical research · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Diagnosis and staging of cardiac masses: additional value of CMR withEuropean journal of nuclear medicine and molecular imaging · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. European journal of nuclear medicine and molecular imaging · 2020
    Article
  19. Cardiac magnetic resonance imaging of primary cardiac tumors.Quantitative imaging in medicine and surgery · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Stephen LiddyDepartment of Radiology, Tallaght University Hospital, Tallaght, Dublin, 24, Ireland. stephenliddy@gmail.com.
Colin McQuadeDepartment of Radiology, Tallaght University Hospital, Tallaght, Dublin, 24, Ireland.
Kevin P WalshDepartment of Cardiology, Mater Misericordiae University Hospital, Dublin, 1, Ireland.
Bryan LooDepartment of Cardiology, Tallaght University Hospital, Tallaght, Dublin, 24, Ireland.
Orla BuckleyDepartment of Radiology, Tallaght University Hospital, Tallaght, Dublin, 24, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThe purpose of this review is to (1) review the recent evidence examining the use of CT and CMR in the assessment of a suspected cardiac mass, (2) summarize the typical imaging features of the most common cardiac masses, and (3) examine the latest developments in the use of three-dimensional reconstructions and models in the preoperative assessment of a cardiac mass. RECENT

findingsCMR can distinguish between tumors and non-tumor masses and between benign and malignant mass with a high degree of accuracy. CT and CMR are complementary tools in the evaluation of cardiac masses. CMR is the preferred initial imaging modality due to its versatile imaging planes and superior tissue characterization. CT better depicts calcification and has a higher spatial resolution compared with CMR, which is of particular importance in preoperative planning. CT also offers a valuable alternative in those with contraindications to CMR. Three-dimensional reconstructions, particularly of CT datasets, are a valuable adjunct in the preoperative assessment of a cardiac mass and may allow a better appreciation of the margins of the mass and its relationship with surrounding structures. Three-dimensional printing is an emerging technology which may be of additional value in selected patients with a cardiac mass.

Indexed as

Heart DiseasesHeart NeoplasmsHumansImaging, Three-DimensionalMagnetic Resonance ImagingModels, AnatomicModels, CardiovascularPreoperative CarePrinting, Three-DimensionalTomography, X-Ray ComputedComputed tomographyHeart neoplasmImagingMagnetic resonance imagingThree-dimensional

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.